Home > NF-κB & IAP & > Triptolide

Triptolide

雷公藤甲素,NSC 163062,PG490

Triptolide是由中草药-雷公藤中提取的免疫抑制剂。

目录号
EY0645
EY0645
EY0645
纯度
99.28%
99.28%
99.28%
规格
1 mg
5 mg
10 mg
原价
498
1090
1800
售价
498
1090
1800
库存
现货
现货
现货
订购
订购
订购
订购
订购
订购
  • 生物活性

    Triptolide inhibits DNA-dependent ATPase activity of XBP and induces inhibition of RNA polymerase II (RNAPII)-mediated transcription (IC50 = 200 nM). Blocks RNA synthesis in HeLa cells (IC50 = 62 nM); exhibits potent antiproliferative activity in 60 cancer cell lines (average IC50 = 12 nM) and induces apoptosis by blocking TNF-α-mediated c-IAP1 and c-IAP2 induction. Triptolide has been shown to induce apoptosis of T lymphocytes by activating caspases, displaying an increase of DEVD-cleavable caspase activity correlated with the apoptosis. The proliferation of rheumatoid synovial fibroblasts characteristic of rheumatoid arthritis was similarly suppressed by treatment with Triptolide through an increase in caspase-3 activity. Cytokine gene expression in blood lymphocytes and T-cells are also suppressed by Triptolide, blocking the transcriptional activation of purine-box/antigen receptor response element/nuclear factor of activated T-cells (NF-AT) and of NF-kappaB. Also displays immunosuppressive and anti-inflammatory activity.

  • 体外研究

  • 体内研究

  • 激酶实验

  • 细胞实验

    Cells


    MCF-7 cells were were cultured in phenolred-free medium.

    AntiproliferativeActivity

    Antiproliferative activity was determined usingthe colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide(MTT) method. Cells were grown on tissue culture flasks in Dulbecco’s ModifiedEagle’s Medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS) andantibiotics (100 U/ml penicillin G, 100μg/mlstreptomycin) at 378C in 5% CO2 and 95% air in a humidified incubator.At the start of the experiment, the cell suspension at a density of 1 3 105 wastransferred to 96-well microplates (180μl/well).After 24 h of cell culture, the medium was replaced by 10% dextrancharcoal(DCC) treated FBS which containing 10, 50, and 100 nM triptolide, 1 nM of E2alone or the combination of triptolide and E2 for 24, 48, and 72 h,respectively. At the end of treatment period, 20 mL of MTT reagent (5 mg/ml inPBS) was added to each well. The plates were then incubated for 4 h at 37oCin the dark. The medium was removed and MTT reduction product (formazancrystals) was dissolved in Dimethyl Sulfoxide (DMSO), and the absorbance at 570nm was measured with an ELISA reader.




  • 动物实验

    Xenograft tumor model


    Six-week-old NOD.CB17 Prkdcscid/J mice weremaintained in a microisolator in pathogen-free conditions. The mice weredivided into four groups; each mouse in each group (n = 5; 5-FU, n = 3) wassubcutaneously injected with 2 × 106 of both SAS and SAS coculturedwith macrophage-like U937 cells. Three days later, the mice in each group werefurther treated with triptolide (TPL) (0.15 mg/kg/day) and 5-FU (12 mg/kg/day),and a vehicle control (PBS) was then separately administered to the groupsthrough intraperitoneal (ip) injection. The size of the transplanted tumors wasmeasured using gauged calipers twice a week, and the tumor volume wascalculated using the following formula: volume (V) = 1/2 × (length × width2).At the end of the treatment, the mice were sacrificed, and the tumors wereremoved, weighed, and photographed.



  • 不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

    动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 AKm系数


    例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。


  • 参考文献

    [1] Qiu, D., et al. 1999. J. Biol. Chem. 274: 13443-13450.
    [2] Kusunoki, N., et al. 2004. BMC Pharmacol. 4 :2.
    [3] Liacini, A., et al. 2005. Biochem. Biophys. Res. Commun. 327: 320-327.

    分子式
    C20H24O6
    分子量
    360.4
    CAS号
    38748-32-2
    储存方式
    ﹣20 ℃冷藏长期储存。冰袋运输
    溶剂(常温)
    DMSO
    30 mg/mL
    Water
    <1 mg/mL
    Ethanol
    1 mg/mL

    体内溶解度

  • Clinical Trial Information ( data from http://clinicaltrials.gov )

    NCT Number Conditions Interventions Sponsor/Collaborators Phases Start Date Last Updated
    NCT02115659 Autosomal Dominant Polycystic Kidney Disease (ADPKD) Drug: Triptolide-Containing Formulation|Drug: Placebo Shanghai Changzheng Hospital Phase 3 2014-04-01 2014-04-16
    NCT01817283 HIV Drug: Triptolide|Drug: cART|Drug: placebo LI Taisheng|Peking Union Medical College Phase 1|Phase 2 2013-01-01 2013-03-22
    NCT00801268 Polycystic Kidney Drug: tripterygium wilfordii|Drug: Emodin Zhi-Hong Liu, M.D.|Nanjing University School of Medicine 2008-11-01 2015-03-27
    NCT02002286 HIV Drug: Tripterygium Wilfordii Hook F extract (TwHF extract)|Drug: cART LI Taisheng|Peking Union Medical College 2011-08-01 2013-11-29
    NCT02044952 Inflammatory Bowel Diseases|Crohn's Disease|Gastrointestinal Diseases|Digestive System Diseases|Intestinal Diseases Drug: Mesalazine, Tripterygium glycosides Zhu Weiming|Jinling Hospital, China Phase 2|Phase 3 2014-01-01 2014-01-22

    注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。

  • 相关化合物库

  • 使用AMQUAR产品发表文献后请联系我们

相关推荐

X
  • 联系人 :
  • 收件地址 :
  • 电话号码 :
  • 单位名称 :
  • 产品货号 :
  • 产品规格 :
  • 发票抬头以及单位税号 :